Fostriecin sodium salt
Cat. No. 1840
Chemical Name: (6R)-5,6-Dihydro-6-[(1E,3R,4R,6R,7Z
Biological ActivityOriginally identified as an antitumor antibiotic from Streptomyces pulveraceous. Displays potent inhibition of protein phosphatase types 2A (PP2A) and 4 (PP4) with IC50 values of 1.5 nM and 3 nM respectively. Also exhibits weaker inhibition of topoisomerase II (IC50 = 40 μM) and protein phosphatase type 1 (PP1) (IC50 = 131 μM) with no apparent inhibition of protein phosphatase type 2B (PP2B). Active in vivo.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Safety Data Sheet
Tunac et al (1983) Novel antitumor agents CI-920, PD 113,270 and PD 113,271. I. Taxonomy, fermentation and biological properties. J.Antibiot. 36 1595. PMID: 6689323.
Walsh et al (1997) Fostriecin, an antitumor antibiotic with inhibitory activity against serine/threonine protein phosphatases types 1 (PP1) and 2A (PP2A), is highly selective for PP2A. FEBS Lett. 416 230. PMID: 9373158.
Hastie and Cohen (1998) Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters. FEBS Lett. 431 357. PMID: 9714542.
If you know of a relevant citation for this product please let us know.
View Related Products by Product Action
Keywords: Fostriecin sodium salt, supplier, Potent, PP2A, PP4, inhibitors, Calcineurin, Protein, Ser/Thr, protein, phosphatases, 2A, 4, antibiotics, Tocris Bioscience, Protein Ser/Thr Phosphatase Inhibitors
Find multiple products by catalog number
New Products in this Area
Cell permeable NFAT inhibitorSephin 1
Inhibitor of the regulatory subunit PPP1R15A of protein phosphatase 1SF 1670
March 19 - 23, 2016
Denver, CO, USA